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Abstract.  Two regions on the clathrin heavy chain 
that are involved in triskelion interactions during as- 
sembly have been localized on the triskelion structure. 
These regions were previously identified with anti- 
heavy chain monoclonal antibodies X19 and X35, 
which disrupt clathrin assembly (Blank,  G.  S.,  and 
E  M.  Brodsky,  1986, EMBO (Eur. Mol.  Biol.  Organ.) 
J.,  5:2087-2095).  Antibody-binding sites were deter- 
mined based on their reactivity with truncated triskel- 
ions, and were mapped to an 8-kD region in the mid- 
dle of the proximal portion of the triskelion arm (X19) 
and a 6-kD region at the triskelion elbow (X35).  The 
elbow site implicated in triskelion assembly was also 
shown to be included within a heavy chain region in- 
volved in binding the light chains and to constitute 
part of the light chain-binding  site.  We postulate that 
this region of the heavy chain binds to the interaction 
site identified on the light chains that has homology to 
intermediate filament proteins (Brodsky, E  M.,  C. J. 
Galloway,  G.  S. Blank,  A.  P. Jackson, H.-E  Scow, K. 
Drickamer,  and P. Parham,  1987, Nature  (Lond.), 
326:203-205).  These findings suggest the existence of 
a heavy chain site, near the triskelion elbow, which is 
involved in both intramolecular and intermolecular in- 
teractions during clathrin  assembly. 
URING the process of receptor-mediated  endocytosis, 
the plasma membrane of a cell invaginates to form 
a coated pit, which subsequently pinches off into the 
cytoplasm to become a coated vesicle (11). The coat of these 
organdies is formed by polymerization of the protein clath- 
rin  on the cytoplasmic  face of the invaginating  membrane 
(29).  Clathrin  assembled on coated pits and coated vesicles 
forms a lattice-like,  polyhedral structure  composed of hexa- 
gons and pentagons  (8,  12,  15). Purified clathrin  will also 
self-assemble in vitro under the appropriate  ionic conditions 
(pH 6.0-6.5), forming  "baskets" with a structure  similar  to 
that seen on the surface of coated vesicles (16, 26, 34, 44). 
Depolymerized clathrin  exists  in  the form of a  triskelion 
which is composed of three identical heavy chains (180 kD) 
and three light  chains  of two types, LC~ and LCb (30-40 
kD) (9, 17, 39). Analysis of the tfiskelion shape and dimen- 
sions has generated a working model of how these triskelions 
associate during assembly (9, 13, 18). Based on stoichiomet- 
ric and electron microscopic data, it is apparent that the ver- 
tex of one triskelion is located at each vertex formed between 
hexagonal and pentagonal  faces of assembled clathrin,  and 
each ann spans two edges.  This arrangement  indicates  that 
the edge of each pentagon or hexagon is composed of arms 
from four different triskelions,  implying extensive lateral in- 
teractions  between the triskelion  arms. 
The clathrin  light chains have been localized to the vertex 
of the triskelion  (19, 40, 42), and antibody binding data sug- 
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gests they span the entire proximal portion of the arm, from 
the vertex to the elbow (38).  Consistent  with this extended 
interaction,  the light chains have a region of homology with 
intermediate  filament  proteins  which  is  involved  in  their 
binding to clathrin  heavy chains (4, 14, 20). The role of the 
clathrin light chain subunits in triskelion assembly is not yet 
completely defined. The light chains have biochemical prop- 
erties  expected of regulatory proteins  that  include  tissue 
polymorphism (6, 28), differential  phosphorylation (1,  33, 
41), and calcium-calmodulin binding (22, 23, 25). They are 
also the recognition  site for a protein which causes clath- 
tin  depolymerization  in  an  ATP-dependent  reaction  (31). 
Whether their presence is required for assembly is unclear. 
Removal of the light chains  from triskelions  by proteolysis 
renders the triskelions assembly-incompetent  (17). However, 
separation  of the subunits by chromatography  in chaotropic 
salts yields heavy chain triskelions  which can assemble into 
clathrin  baskets (43).  Although  incomplete light chain  dis- 
sociation has been demonstrated in this latter procedure (31), 
and the efficiency of heavy chain  reassembly has not been 
characterized,  these data  indicate  that  the  clathrin  heavy 
chain provides the structural  backbone for assembled clath- 
rin.  This  is confirmed by the fact that  mild proteolysis of 
clathrin  baskets removes the light chains without disrupting 
the basket structure  (42). 
Consistent  with a prominent role for heavy chain interac- 
tions  during  clathrin  assembly,  we have  identified  three 
anti-heavy chain monoclonal antibodies (mAbs) that inhibit 
assembly and induce formation  of abnormal clathrin  struc- 
tures (2). We have shown previously that these antibodies re- 
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which seem to be critical for arm-arm interactions during as- 
sembly. In the studies described in this paper, sequential pro- 
teolysis has been used to map these epitopes with respect to 
their physical position along the triskelion arm. One epitope 
is included in an 8-kD segment of the heavy chain at the mid- 
point of the proximal portion of the arm. The second epitope 
localizes to a 6-kD segment at the triskelion elbow. This sec- 
ond site is also demonstrated to be involved in heavy chain 
binding of clathrin light chains, defining a heavy chain re- 
gion which mediates both intramolecular and intermolecular 
interactions. 
Materials and Methods 
Clathrin Preparation and Proteolysis 
Clathrin was purified from bovine brain-coated vesicles as described by 
Blank and Brodsky (2), and modified from Pearse and Robinson (30). 
Conditions were established to optimize proteolysis of terminal domain 
from the triskelion core (18, 32). Clathrin was assembled into baskets by 
overnight dialysis (4~  against 20 mM 2-(N-morpholino)ethane sulfonic 
acid (MES), 2 mM CaCl2,  pH 6.2. L-l-p-t0sylamino-2-phenylethyl  chloro- 
methyl ketone (TPCK)-trypsin (Worthington Biochemical Corp., Freehold, 
NJ)  was added to clathrin baskets at trypsin/clathrin ratios of 1:1130 and 
1:200, and the solution was incubated at 37~  Samples were removed after 
0, 0.5,  l, 2, 3, and 4 h, and the digestion stopped by the addition of soybean 
trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) in 2X molar excess 
to trypsin. Digestion products were analyzed by SDS-PAGE. Digestion con- 
ditions were chosen which totally eliminated the 180-kD heavy chain yet 
gave the greatest yield of 100-120 kD core material. The digestion was then 
repeated using 6-8 nag of clathrin. After stopping the reaction, baskets were 
depolymerized by slowly raising the pH to 7.4 with 0.1 N NaOH. Remaining 
intact baskets and aggregates were removed by centrifugation at 30000 g 
for 10 min, then proteolyzed clathrin was separated into fragments by size 
exclusion high pressure liquid chromatography (HPLC). 
HPLC fractions from the above preparation containing core (100-120 kD) 
were pooled and subjected to additional proteolytic digestion. TPCK-tryp- 
sin was added to give a trypsin ratio of 1:150, and the solution incubated 
at 37~  for 5,  10, 20, and 50 min. The reaction was stopped by addition of 
2X molar excess soybean trypsin inhibitor to trypsin. These digests were 
centrifuged at 30,000 g for 10 rain, and analyzed by size exclusion HPLC 
as described below. 
HPLC 
Clathrin digests were analyzed and purified by size exclusion HPLC using 
a model 334 system with a Spherogel TSK-3000SW 0.75 x  30-cm column 
(Beckman  Instruments,  Inc.,  Palo  Alto,  CA).  Clathrin  fragments were 
loaded and eluted at 0.2 ml/min in 50 mM ammonium bicarbonate, pH 7.4. 
1-min fractions were collected, so that the fraction number corresponds to 
the elution time. The column was calibrated using the above conditions with 
BioRad Laboratories gel filtration standards which include thyroglobulin, 
670 kD;  IgG,  158 kD; ovalhumin, 44 kD; and myoglobin, 17 kD. 
Electrophoresis 
SDS-PAGE was by  the method of Laemmli  (21). Low molecular mass 
marker proteins were from Pharmacia Fine Chemicals, Piscataway, N J, and 
include phosphorylase b (94 kD), bovine serum albumin (67 kD), ovalbu- 
min (44 kD),  soybean trypsin inhibitor (20 kD), and r  (14.4 
kD). High molecular mass marker proteins were from BioRad Laboratories, 
Richmond, CA, and include myosin (200 kD),  ~galactosidase (116 kD), 
phosphorylase b, bovine serum albumin, and ovalbumin. 
MAb Reactivity 
Production of anti-clathrin mAbs X19, X22, X35, and control antibody 
anti-Leu 10-has been previously described (2, 3, 7). Anti-Leu 10 reacts with 
HLA-DQ cell surface antigens and does not react with clathrin (3, 7). MAbs 
were purified from ascites fluid, as described (27). 
Binding of mAbs to clathrin fragments was determined by indirect radio- 
immunoassay (3).  20-1tl samples of HPLC fractions were applied to wells 
of polyvinyl chloride microtiter plates and incubated for 90 min at room 
temperature. After washing and blocking with 0.5% bovine serum albumin 
in phosphate buffer, pH 7.4 (PBS/BSA), 50 gl of mAb (5 p,g/ml) was added 
to each well and incubated for 90 min at 4~  The wells were washed with 
PBS/BSA and  20  I11  t25I-F(ab')2 of rabbit anti-mouse immunoglobulin 
(t25I-RAM)  containing 300,000  cpm was added per well.  This  was  in- 
cubated for 60 min at 4~  The wells were washed and the bound radioactiv- 
ity was counted. 
Western blot analysis was carried out, as previously described (19), with 
the following modifications. Protein samples were run in three identical sets 
on SDS-PAGE and transferred electropboretically to nitrocellulose at 20 W 
for 1 h. The nitrocellulose was then stained with Amido Black and cut into 
three panels for incubation with mAbs X22 or anti-Leu 10, or retained for 
total protein staining. Anti-Leu 10 was used as a control for nonspecific 
binding. For antibody binding, two panels were treated with Tris-buffered 
saline (TBS, I  10 mM Tris,  150 mM NaCI,  pH  7.4,  0.1%  Triton X-100, 
0.02%  SDS) containing 3% BSA and 0.1% normal goat serum for 1 h at 
37~  MAbs were then added in the above solution at a concentration of 
5 gg/ml and incubated overnight at room temperature. The panels were then 
washed five times  with  TBS  and  treated  with  horseradish peroxidase- 
conjugated goat anti-mouse immunoglobulin in TBS plus 3%  BSA and 
0.1% normal goat serum for 2 h at room temperature. The panels were then 
washed five times with TBS and five times with TBS without detergent. Per- 
oxidase  was detected by  incubation in  substrate Y-Y-diaminobenzidine 
tetrahydrochloride (50 ~tg/ml in TBS without detergent) followed by addi- 
tion of 30%  hydrogen peroxide to a final  concentration of 0.01%. 
Light Chain Binding Studies 
Clathrin light chains were purified from bovine brain-coated vesicles by 
heat treatment (5, 23) and DEAE chromatography (38)  as previously de- 
scribed (4). They were then iodinated using Enzymobeads (BioRad Labora- 
tories) with 1 mCi ~25I-NaI per 25 gg. Iodinated light chains were tested 
for binding to preparations of clathrin heavy chain, triskelion core, and 
HPLC fractions containing truncated triskelions by direct radioimmunoas- 
say (RIA) (4). When binding to heavy chain fragments was tested, saturating 
concentrations of iodinated light chains were used.  When the effects of 
anti-heavy chain mAbs on light chain-heavy chain association were tested, 
heavy chains were preincubated with dilutions of mAbs for 30 min before 
adding iodinated light chains. Heavy chains were produced by limited pro- 
teolysis of triskelions under conditions which removed the light chains but 
did not cleave the heavy chains (4,  17). Fab fragments used in these studies 
were produced from purified mAbs, as described (2, 27). 
Results 
We have previously found three mAbs binding to two distinct 
antigenic  sites on the heavy chain,  which are involved in 
clathrin assembly (2). To determine the position of  these epi- 
topes with respect to the triskelion form, clathrin was proteo- 
lyzed and the resulting fragments were analyzed for their 
ability to bind mAbs. These truncated triskelions were also 
tested for binding of clathrin light chains. Binding activity 
was then correlated with fragment size to determine the rela- 
tive positions of mAb-binding sites along the heavy chain, 
and the region of light chain interaction. 
Generation of Truncated Triskelions 
Limited proteolysis of assembled clathrin baskets has been 
shown to remove light chains and to fragment the heavy chain 
into a triskelion core composed of three 100-120 kD arms, 
liberating globular terminal domains  (40-60 kD)  (18, 32, 
40). Separation of clathrin heavy chain into these two rela- 
tively large fragments allowed initial localization of mAb- 
binding sites and provided starting material for further pro- 
teolysis. To determine optimal conditions for generation of 
the triskelion core, clathrin baskets were digested for varying 
1. Abbreviations used in this paper: RAM, rabbit anti-mouse (immunoglob- 
ulin G); TBS, Tris-buffered saline. 
The Journal  of Cell Biology,  Volume 105, 1987  2012 Figure L Purification of triskelion core fragments. (A) HPLC separation of triskelion fragments produced by trypsin digestion of clathrin 
baskets. Clathrin baskets (6 mg) were digested with trypsin at a ratio of 1:200 and depolymerized, and fragments were separated by size 
exclusion HPLC as described in Materials and Methods. (Inset) Gel filtration standards were chromatographed under the same conditions 
used for digested clathrin. The elution times of these standards were plotted versus molecular mass. (B) SDS-PAGE analysis of HPLC 
fractions. 1-min  fractions were collected during the HPLC separation of digested clathrin shown in A. Elution time in minutes corresponds 
to fraction number (lanes labeled 8-40). Lane A, high molecular mass marker proteins plus clathrin heavy chain (HC); lane B, digested 
clathrin prior to HPLC separation. (C) MAb binding to HPLC fractions. Binding of mAbs X22 (e), X19 (I), and X35 (A) to clathrin 
fragments in fractions 8--42 (A and B above) was determined by indirect, solid-phase RIA. The bars represent mAb binding to undigested 
clathrin.  MAb binding was detected with iodinated F(ab~2 of rabbit anti-mouse  immunoglobulin (125I-RAM). 
times using two different concentrations of  trypsin. Based on 
this trial proteolysis, clathrin baskets were digested under 
conditions which maximized the yield of 100-120-kD frag- 
ments and elimination of  the 180-kD heavy chain. The diges- 
tion products were separated by size exclusion HPLC under 
nondenaturing conditions. An initial peak eluted at 12 min, 
which corresponds to a molecular mass of '~360 kD. A sec- 
ond, much smaller peak eluted at 27 min and corresponds 
to a molecular mass of,'-,45 kD (Fig. 1 A). When these frac- 
tions were analyzed by SDS-PAGE, the high molecular mass 
peak consisted mainly of 100-120-kD fragments with some 
undigested 180-kD heavy chain (Fig. 1 B). These fragments 
were still in triskelion form and their elution position from 
HPLC corresponded to three times the molecular mass of  the 
denatured fragments in SDS-PAGE. The second peak con- 
sisted of two fragments of 43 and 55 kD derived from the 
terminal domain. The presence of triskelion core and termi- 
nal domain was confirmed by electron microscopy of rotary- 
shadowed samples from HPLC fractions (18, 37, 39). 
To generate smaller fragments for localization of mAb- 
binding sites, HPLC fractions containing 100-120-kD frag- 
ments were pooled and further digested with trypsin for in- 
creasing times (5,  10, 20, and 50 min). These digests were 
then separated by size exclusion HPLC. The 5-min digest 
eluted as a single, relatively broad peak, from 12 to 16 min. 
With increased digestion times, the major elution peak be- 
came smaller and shifted towards the right with the appear- 
ance of several smaller peaks in the trailing shoulder. The 
elution position of the major peak at all four digest times was 
consistent  with  that  of an  increasingly  smaller triskelion 
form. This indicated that truncated triskelions were being 
generated by cleavage from the distal ends of the triskelion 
arms.  To determine the size of the arms,  HPLC fractions 
from each time point were analyzed by SDS-PAGE (Fig. 2). 
This analysis demonstrated that cleavage occurred at discrete 
sites producing arms of 90,  62,  56,  46,  and 38 kD.  With 
longer digestion time there was an increase of the lower mo- 
lecular mass species corresponding to disappearance of the 
higher molecular mass  fragments.  The smallest truncated 
triskelion isolated by size exclusion HPLC was composed of 
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ments detected by Western blot.  Protein samples were 
applied to a polyacrylamide gel in three identical sets. 
After SDS-PAGE and electrophoretic transfer to nitro- 
cellulose,  one set of samples was stained with Amido 
Black to detect total protein.  The other set of samples 
was tested for reactivity with mAb X22 and a control 
mAb as described  in Materials and Methods.  Lane 1, 
clathrin; lane 2, triskelion core (Fig. 1 B, lane 10); lane 
3, terminal domain (Fig.  1 B, lane 38); lanes 4, 5, 6, 
fragments of triskelion core from HPLC separations of 
timed digests shown in Fig. 2: respectively, fraction 12 
(5-min digest), fraction 18 (20-min digest), fraction 20 
(50-min digest). Migration positions of  molecular mass 
marker proteins are indicated along the left edges. No 
binding was detected when samples were reacted with 
control antibody. 
38-kD heavy chain fragments and had a molecular mass of 
114 kD. 
Localization of  Antigenic Sites Involved in Assembly 
To localize functional sites on the clathrin triskelion,  anti- 
clathrin mAbs were tested for binding to truncated triskelions 
using  an  indirect  solid-phase  RIA.  The  antibodies  tested 
(X19, X22, and X35) represent three types of antibodies that 
have different effects on clathrin assembly (2). X19 and X35 
inhibit assembly, producing loose aggregates of triskelions 
or abnormally assembled structures,  respectively. X22 has 
no detectable effect on clathrin assembly. Competition stud- 
ies have indicated  that these three mAbs bind to different 
sites on the clathrin triskelion. MAbs were initially tested for 
their ability to bind to either triskelion core or terminal do- 
main.  As seen in Fig.  1 C, these three mAbs reacted with 
HPLC fractions containing  triskelion core. 
For  further  localization  of mAb-binding sites along the 
triskelion  core  fragment,  secondary  tryptic digests  of the 
core were separated by HPLC and fractions analyzed for an- 
tibody binding by solid-phase RIA (Fig. 2). The position of 
mAb-binding sites on the triskelion was determined by cor- 
relating binding activity with the fragment sizes present in 
each fraction.  Because X35 binding activity was lost first, 
the X35 site must lie farthest from the vertex along the heavy 
chain. In the 5-min digest, X35 binding was associated with 
fractions containing the 90,  62, and 56 kD fragments. Ana- 
lyzing the 10-min digest where the 90-kD fragment is absent 
indicates that X35 binding activity correlates with the 62-kD 
fragment, but not with the 56-kD fragment. In addition, there 
is no X35 reactivity with the 20- or 50-min digests in which 
the 56-kD fragment is the largest fragment present.  Thus, 
X35 binds within the 6-kD portion of the heavy chain be- 
tween the 56- and 62-kD fragments. Kirchhausen and Hard- 
son (18) have estimated the mass per unit length of the prox- 
imal segment of the triskelion arm to be 4.2 kD/nm. Using 
this value, X35 binds to a region 13-15 nm from the vertex 
along the proximal segment. 
X19  reactivity is considerably reduced between 20- and 
50-min digestion, localizing the X19-binding  site closer to 
the triskelion vertex than the X35-binding site. X19 binding 
is associated with the 56- and 46-kD fragments in the 20-min 
digest, but does not correlate with the presence of the 38-kD 
fragment. The 50-min digest demonstrates that X19 binds to 
fractions containing the 46- and 38-kD fragments, but does 
not react with the major peak of the 38-kD fragment. Thus, 
the X19-binding site lies between the cleavage sites produc- 
ing the 46- and 38-kD fragments. This localizes the X19 site 
to a  region of 8-kD, spanning 9-11  nm from the vertex. 
As  a  reference  point,  an  anti-heavy  chain  mAb  (X22) 
which does not affect assembly (2) was also tested for reac- 
tivity with truncated triskelions. As measured by RIA in Fig. 
2,  X22  reacts with all the fragments generated by trypsin 
digestion of triskelion core. It was possible to confirm this 
reactivity by Western blotting with X22, in that it is the only 
antibody of the three which binds to denatured clathrin heavy 
chain (3) (Fig. 3). As predicted by RIA, X22 binds in a West- 
ern  blot to triskelion  core and  its fragments of 90-38  kD 
(lanes 4-6), but does not react with terminal domain (lane 
Figure 2. Analysis of timed trypsin digests of triskelion core. Fractions containing triskelion core (trimerized 100-120-kD fragments), from 
the separation shown in Fig. 1, were pooled and subjected to further trypsin digestion for 5, 10, 20, and 50 min. Digests were then separated 
by HPLC as described  in Fig.  1. HPLC fractions were analyzed by SDS-PAGE and indirect,  solid-phase RIA. Molecular mass markers 
across the top of the panels (158 kD, 46 kD) indicate their time of elution during HPLC with respect to the fraction numbers below. (LeB) 
SDS-PAGE panels: lane A, molecular mass markers plus clathrin (indicated along left side-HC, clathrin heavy chain; LC, clathrin light 
chains); lane B, triskelion core before additional digestion; lane C, timed digest of triskelion core before HPLC separation. HPLC fraction 
numbers at the bottom correspond to their time of elution. (Right) RIA binding panels: binding of mAbs X22 (e), X19 (D), and X35 (A). 
The bars represent mAb binding to undigested clathrin (Cl) or triskelion core (TO). MAb binding was measured by indirect,  solid-phase 
RIA using  125I-RAM. 
Blank and Brodsky Clathrin Assembly Interaction Sites  2015 Figure 4.  Diagram of a clathrin  triskelion  based on the work of 
Crowther and Pearse (9), and Kirchhausen and Harrison (18) show- 
ing the binding sites for each of  the mAbs. The X22, X19, and X35 
epitopes  were  localized  based  on antibody  binding  to truncated 
triskelions and mapped on the triskelion, using an estimate of 4.2 
kD/nm (18). 
3). Blotting of X22 also confirmed that the 90-, 62-, 56-, 46-, 
and 38-kD fragments are all generated by progressive diges- 
tion of the triskelion core. We have been unable to generate 
a truncated triskelion with fragments smaller than 38 kD to 
establish the location of the X22 site more precisely. Thus, 
X22 binds somewhere between the vertex and 9 nm along the 
region of the arm proximal to the vertex, using the estimate 
of 4.2 kD/nm (18).  Measurements of negatively stained tri- 
skelions have indicated that the proximal region of the arm 
extends 16 -I- 1 nm from the vertex to the elbow, with the dis- 
tal region of the ann having an approximate length (elbow 
to terminal domain) of 26 nm (9,  13,  18). This localizes the 
binding sites of all three mAbs to the proximal arm of the 
clathrin heavy chain, as shown in Fig. 4. The binding simms, 
proceeding from the vertex in order are X22, X19, and X35, 
with the X35 site on the proximal portion of the triskelion 
elbow. 
An Assembly Interaction Site Is Involved in 
Light Chain Binding 
In addition  to localizing the mAb-binding sites,  truncated 
triskelions  were used to analyze the  region of light chain 
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Figure 5. MAb effects on light chain-heavy chain reassociation. Io- 
dinated light chains were tested for binding to clathrin heavy chains 
in the presence  of mAbs and unlabeled light chains.  (A and C) 
~25I-LCa binding  to heavy chain;  (B and D)  125I-LCb  binding  to 
heavy chain. Before adding iodinated light chains, increasing dilu- 
tions of IgG were preincubated with the heavy chain in A and B. 
Fab fragments were used for preincubation in C and D. MAbs tested 
in both IgG and Fab form were X19 (m), X22 (o), and X35 (v). 
Unlabeled  LC~ (,x) and LCb (,t) were used as control inhibitors. 
binding.  Purified,  iodinammd clathrin  light chains  (LCa or 
LCb) were tested for their ability to bind to HPLC fractions 
containing triskelion core (100-120-kD arms) and fragments 
of core (56- and 46-kD arms). These fractions were selected 
from HPLC separations of trypsin digests of clathrin,  such 
as the ones shown in Figs. 1 and 2. In order to compare bind- 
ing between samples that varied in protein concentration, 
X22 binding was measured and used to normalize the radio- 
activity bound,  because X22 reacts with all the fragments 
tested. Initially, several dilutions of each fraction containing 
heavy chain fragments were tested to be sure that antibody 
binding  and  light  chain  binding  were  measured  under 
saturating conditions. The results listed in Table I were cal- 
culated from binding to a triskelion core preparation, plated 
at ,,o25 ttg/ml,  and binding  to HPLC fractions containing 
lower concentration  of protein.  X22 binding  to triskelion 
core was set at 100% for each experiment so that the relative 
concentrations  of heavy chain  fragments in  the  fractions 
could be determined using X22 binding. LCa and LCb both 
bind to triskelion core. Their lack of reactivity with the trun- 
Table L Light Chain and MAb Binding to Truncated Triskelions* 
MAb binding  Light chain binding 
Heavy chain fragments 
in triskelion form  X22  X35  LC~  LCb 
/o9  % 
100-12C (core)  100  41.0  +  5.0  30.5 +  7.3  55.5 5:16.5 
56  54.5 5:17.7  2.1  + 0.9  3.2  +  2.2  5.4  +  5.0 
46  +  56  71.0  5:31.5  2.2  +  0.8  3.4  +  2.7  5.1  + 4.1 
38  30.0  +  15.9  2.2  + 0.8  2.8  5:1.9  3.3  5:2.7 
*MAbs (X22 and X35) and iodinated clathrin light chains (LC~ and LCb) were tested for binding to HPLC fractions containing triskelion core and truncated 
triskelions. Binding was measured by indirect and direct RIA under saturating conditions. Results are reported as a percentage of X22 binding to triskelion core. 
Results shown are the average of three experiments testing fragments from two separate digests. Separate  binding experiments using nonsaturating conditions 
confirmed X19 reactivity  with the 46-kD, 56-kD, and core fragments. 
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from the reduction in fragment concentration demonstrated 
by X22 binding. This indicates that a critical region involved 
in  light  chain-heavy  chain  interaction  is  present  in  the 
triskelion core distal to the 56-kD cleavage site. As expected 
from the mapping studies described above, this distal part of 
the triskelion core contains the X35 binding site but not the 
X19 or X22 sites. 
It has been previously demonstrated that X35 binds with 
greater avidity to clathrin heavy chain when the light chains 
have been dissociated than when the light chains are attached 
(2). This suggested that X35 recognizes a heavy chain site 
involved in light chain binding and correlates with the loca- 
tion of the X35 site within the distal part of the triskelion 
core, which contains a  light chain interaction region. The 
role of the X35 site in light chain binding was further inves- 
tigated by antibody blocking studies (Fig. 5). We have previ- 
ously shown that light chain-heavy chain interactions can be 
studied by binding iodinated light chains to heavy chains 
which have been stripped of light chains by proteolysis (4). 
When clathrin heavy chains were preincubated with X35 
IgG, reassociation of iodinated LC~ or LCb with the heavy 
chain was slightly inhibited (,~25 % at maximum IgG con- 
centrations). In contrast, preincubation with X22 IgG had no 
effect on light chain reassociation, whereas preincubation 
with X19 IgG slightly enhanced the degree of light chain 
binding.  These results suggest that X35  and X19  binding 
influence light chain association with heavy chain, and that 
the X35  site may be directly involved in this association. 
When this experiment was repeated using Fab fragments, the 
relative effects of each antibody were similar but only margi- 
nally significant. This can be  attributed to the decreased 
avidity of  the univalent Fab fragment in comparison to whole 
IgG and its inability to compete effectively with light chain 
binding. Considered together, the IgG inhibition studies and 
enhanced avidity of  X35 for free heavy chain suggest the X35 
site constitutes part of the light chain-binding region local- 
ized to the distal part of the triskelion core. 
Discussion 
The experiments described above have localized two regions 
on the clathrin heavy chain which are involved in clathrin- 
clathrin interactions during assembly (2). These two regions 
were initially identified in previous studies using mAbs X19 
and X35, which interfere with clathrin assembly (2). In the 
studies reported here, the X19 site has been mapped to an 
8-kD sequence in the center of the proximal portion of the 
triskelion arm. The X35 site has been mapped to a 6-kD se- 
quence on the proximal side of  the elbow bend. We also dem- 
onstrate that the X35 site maps within a region on the heavy 
chain which is involved in light chain binding and constitutes 
part of the light chain-binding site. 
These functional sites were localized on the clathrin tri- 
skelion by testing truncated heavy chain triskelions for bind- 
ing of mAbs or iodinated light chains. Truncated heavy chain 
triskelions were generated by mild trypsin treatment of clath- 
rin triskelion fragments and were composed of heavy chain 
fragments of 90,  62,  56,  46,  and 38 kD  which remained 
joined at the triskelion vertex. The trimeric nature of these 
structures indicates that <25 % of the 180-kD heavy chain is 
needed to maintain the triskelion structure. A Western blot 
with the X22  mAb,  which reacted with all the truncated 
triskelions, confirmed that they were composed of fragments 
which were derived from progressive cleavage from the dis- 
tal ends of the triskelion arms. This allowed orientation of 
the antibody- and light chain-binding sites, based on progres- 
sive loss of binding activity. The approximate physical loca- 
tions of the cleavage sites on the truncated triskelion were 
determined using an estimate of 4.2 kD/nm, proposed by 
Kirchhausen and Harrison (18) from earlier proteolytic stud- 
ies involving larger heavy chain fragments (Fig. 4). Thus, the 
antibody- and  light chain-binding sites  were  assigned  to 
regions on  the  triskelion flanked by proteolytic cleavage 
sites,  defining reactive and nonreactive fragments. 
Colocalization of the X35 mAb binding site and a region 
of interaction with clathrin light chains has been suggested 
by earlier data and supported by the experiments described 
above. We previously showed that X35, which interferes dra- 
matically with  clathrin  assembly,  binds  preferentially to 
clathrin heavy chains when the light chains are removed (2). 
We have demonstrated here that X35 binding also has a slight 
inhibitory effect on  light chain  reassociation with  heavy 
chain. Furthermore, proteolysis of the clathrin heavy chain, 
resulting in loss of the X35-binding site, coincidentally re- 
moves the ability of  truncated heavy chain triskelions to reas- 
sociate with clathrin light chains. In conjunction with data 
localizing light chain binding to the clathrin vertex and the 
proximal portion of the triskelion arm (19, 38, 40, 42, 43), 
these results indicate that light chain-heavy chain interac- 
tions extend minimally from the vertex to a region of strong 
interaction near the elbow.  As might be expected, the X19 
mAb, which binds to an 8-kD region in the center of the 
proximal portion of the triskelion ann, also has an effect on 
light chain-heavy chain reassociation. In this case, it slightly 
enhances light chain binding, possibly by inducing the heavy 
chain into a favorable conformation inasmuch as X19 binds 
equally well to free and light chain-associated heavy (2). Fi- 
nally, the X22 mAb which binds the heavy chain closer to 
the triskelion vertex, has no effect on light chain binding. It 
is possible that the light chain-heavy chain interactions in 
this region are less strong because this region contains the 
tissue-specific polymorphic sequences of the light chains 
(4). 
The locations of the binding sites of the X19 and X35 
mAbs and the extent of light chain interactions can now be 
considered with regard to their respective roles in clath- 
rin assembly. Our previous results showed that X19 Fab frag- 
ments prevent recognizable triskelion-triskelion interactions 
and only allow small clumps to aggregate (2). As shown in 
Fig. 6 B, the X19-binding site is situated such that Fab bind- 
ing would disrupt the proximal portion of the triskelion arm 
from participating in either distal-proximal or proximal- 
proximal interactions and thereby prevent both nucleation 
and further polymerization from taking place. On the other 
hand, binding of X35 Fab fragments would not interfere as 
much with interactions between arms allowing some nuclea- 
tion to take place (Fig. 6 C). However,  the presence of the 
Fab fragments would cause steric problems at the polyhe- 
dron vertices where a triskelion vertex must associate with 
three adjacent elbows during polymerization. It is also possi- 
ble that X35 binding perturbs the triskelion structure at the 
elbow by interfering with light chain interactions in that re- 
gion. Such perturbation could be responsible for the unusual 
angles formed by triskelions in the structures induced by 
coassembly with X35 fragments (Fig. 6 C). Similar triskeli- 
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Figure 6.  Model for the effect of mAbs on clathrin assembly. (A) 
Normal assembly: the triskelion interactions diagrammed here are 
based on models proposed by Crowther and Pearse (9), and Kirch- 
hausen and Harrison (18). This diagram indicates the two types of 
triskelion interactions that occur during assembly involving either 
vertex-distal arm contacts (left) or the vertex-elbow contacts shown 
by addition of a second layer of triskelions (right). This model does 
not attempt to indicate the interweaving of arms which is observed 
in situ (9,  13,  18). The terminal domains which project toward the 
center of an assembled basket (13, 42) have been omitted for clarity. 
(B)  X19  inhibition:  the  squares  represent  XI9  Fab  binding  to 
triskelions (approximately to scale). Their location at the center of 
the proximal portion of the arm would disrupt proximal-distal and 
proximal-proximal arm interactions that occur in both types of triskel- 
ion interactions shown in A. This is a likely explanation for the lack 
of assembly nucleation seen in the presence of XI9 Fab which only 
allows formation of loose triskelion aggregates (2). (C) X35 inhibi- 
tion: the circles represent X35 Fab binding to triskelions (approxi- 
mately to scale). Electron micrographs of clathrin assembled in the 
presence of X35 Fab indicate that some nucleation can occur (2). 
However, it is likely that polymerization is blocked by the inability 
of additional triskelions to make vertex-elbow contacts due to the 
presence of X35 Fab fragments, which may also disrupt the angles 
formed by free arms. The disrupted structure shown is based on 
electron micrographs of clathrin assembled in the presence of X35 
Fab fragments (2). 
on interactions have been reported by Sorger et al. (35) who 
have established  conditions  for forming cubes of clathrin. 
Their results confirm that such interactions  are structurally 
permissible. However, they are also formed under disruptive 
conditions. 
The implication of a light chain-binding region in triskel- 
ion interactions during assembly indicates a possible struc- 
tural role for the light chains, as well as a  role for the light 
chain binding site. The fact that the heavy chain-light chain 
interactions are strong near the elbow suggest the light chain 
may play a  role in stabilizing the angle at the elbow. We, in 
collaboration with Jackson et al. (14), have recently demon- 
strated that the region of light chains that interacts with the 
heavy chain has homology to an a-helical domain which is 
conserved  between  intermediate  filament proteins,  nuclear 
lamins,  and  neurofilament  subunits  and  participates  in  a 
coiled-coil helix structure in these proteins (4,  10, 24,  36). 
In  an  independent  analysis  of the  clathrin  light  chain  se- 
quences based on observation of heptad repeats, Kirchhau- 
sen et al. (20) suggest that the light chains may form a coiled- 
coiled ~t-helix with the heavy chain. These data suggest that 
the light chain-binding  site at the heavy chain elbow might 
have corresponding  secondary  structure  such  that it could 
bind light chains. Involvement of this light chain-binding site 
in triskelion  assembly suggests further  homology with the 
intermediate filament family of proteins in which assembly 
has been shown to result from interaction  between coiled- 
coil  subunits  (36).  Sequence  analysis  of peptides  reactive 
with  the X35  mAb,  which defines the heavy chain  site in- 
volved in intramolecular and intermolecular binding, should 
elucidate  the nature of the structural  interactions  involved. 
We  thank  B.  Abrams and  L.  Kelley  for excellent  technical  assistance, 
P.  Parham for helpful  discussions, and B.  Summey for artwork. 
Received  for publication 5 April  1987, and in revised  form 12 June 1987. 
References 
1. Bar-Zvi,  D., and D. Branton.  1986. Clathrin-coated vesicles contain two 
protein kinase activities. J.  Biol.  Chem. 261:9614-9621. 
2. Blank, G. S., and F. M. Brodsky.  1986. Site-specific disruption of clathrin 
assembly produces novel structures. EMBO (Eur. Mol. Biol. Organ.) J. 
5:2087-2095. 
3. Brodsky, F. M. 1985. Clathrin structure characterized with monocional an- 
tibodies. I. Analysis of multiple antigenic sites. J.  Cell Biol. 101:2047- 
2054. 
4. Brodsky, F. M., C. J. Galloway, G. S. Blank, A. P. Jackson, H.-F. Scow, 
K. Driekamer, and P. Parham.  1987. Localization of clathrin light chain 
sequences mediating heavy-chain binding and coated vesicle diversity. 
Nature  (Lond.).  326:203-205. 
5. Brodsky,  F. M., N. H. Holmes, and P.  Parham.  1983. Tropomysin-like 
properties of clathrin light chains allow a rapid, high-yield purification. 
J.  Cell Biol. 96:911-914. 
6. Brodsky,  F.  M.,  and  P.  Parham.  1983. Polymorphism  in clathrin  light 
chains from different tissues. J.  Mol. Biol. 167:197-204. 
7. Chen, Y-X., R. Evans, M. S. Pollack, L. L. Lanier, J. Phillips, C. Rousso, 
N. L. Warner,  and F. M. Brodsky.  1984. Characterization  and expres- 
sion of the HLA-DC antigens defined by anti-Leu  10.  Hum.  Immunol. 
10:221-235. 
8. Crowther, R. A., J. T. Finch, and B. M. F. Pearse.  1976. On the structure 
of coated vesicles. J.  Mol. Biol. 103:785-798. 
9. Crowther,  R. A., and B. M.  F.  Pearse.  1981. Assembly and packing of 
clathrin  into coats. J.  Cell Biol. 91:790-797. 
10.  Geisler,  N., S. Fischer,  Vanderkerckhove,  U. Plessman,  and K. Weber. 
1984. Hybrid character  of a large neurofilament protein  (N-M):  inter- 
mediate filament type sequence followed by a long and acidic carboxy- 
terminal extension.  EMBO (Fur. Mol. Biol. Organ.) J.  3:2701-2706. 
I 1. Goldstein, J. L., M. S. Brown, R. G. W. Anderson,  D. W. Russell, and 
W. J. Schneider. 1985. Receptor-mediated endocytosis. Annu. Rev. Cell. 
Biol.  1  : 1-39. 
12.  Heuser, J. 1980. Three-dimensional visualization of coated vesicle forma- 
tion in fibroblasts. J.  Cell Biol. 84:560-583. 
13.  Heuser, J., and T. Kirchhausen.  1985. Deep-etch views of clathrin assem- 
blies. J.  Ultrastruct. Res. 92:1-27. 
14. Jackson, A. P., H-F. Scow, N. J. Holmes, K. Drickamer, and P. Parham. 
1987. Clathrin light chains contain brain-specific insertion sequences and 
a region of homology with intermediate filaments. Nature (Lond.). 326: 
154-159. 
15. Kanaseki, T., and K. Kadota. 1969. The "vesicle in a basket": a morpholog- 
The Journal of Cell Biology, Volume  105, 1987  2018 ical study of the coated vesicle isolated  from the nerve endings of the 
guinea pig brain, with special reference to the mechanism  of membrane 
movements. J.  Cell Biol.  42:202-220. 
16. Keen, J. H., M. C. Willingham, and I. H. Pastan. 1979. Clathrin-coated 
vesicles: isolation, dissociation and fuetor-dependent reassociation of 
clathrin baskets. Cell.  16:303-312. 
17. Kirchbansen,  T., and S. C. Harrison. 1981. Protein organization in clathrin 
trimers. Celt.  23:755-761. 
18. Kimhhausen, T., and S. C. Harrison. 1984. Structural domains of clathrin 
heavy chains. J.  Cell BioL 99:1725-1734. 
19. Kirehhausen, T., S. C. Harrison, P. Parham, and F. M. Brodsky. 1983. 
Location and distribution of the light chains in clathrin trimers. Proc. 
Natl. Acad.  Sci.  USA.  80:2481-2485. 
20. Kirchhausen, T., P. Scarmato, S. C. Harrison, J. J. Monroe, E. P. Chow, 
R. J. Mattaliano, K. L. Ramachandran, J. E. Smart, A. H. Ahn, and 
J. Brosius. 1987. Clathrin light chains LeA and LCB are similar, poly- 
morphic and shared repeated heptad motifs. Science (Wash.  DC). 236: 
320-324. 
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly 
of the head of bacteriophage T4. Nature (Lord.).  227:680-685. 
22. Linden, C. D. 1982.  Identification  of the coated vesicle proteins that bind 
calmodulin. Biochem.  Biophys.  Res.  Commun.  109:186-193. 
23. Lisanti, M.  P.,  L. S. Shapiro,  N. Moskowitz, E.  Hua, S. Puszkin, and 
W. Schook, 1982. Isolation and preliminary characterization of clathrin 
associated proteins. Eur.  J.  Biochem.  125:463-470. 
24. McKeon, F. D., M. W. Kirschner, and D. Caput.  1986.  Homologies in 
both primary and secondary structure between nuclear envelope and in- 
termediate filament proteins. Nature (Lord.).  319:463-468. 
25. Mooibroek, M. J., D. F. Michiel, and J. H. Wang. 1987. Clathrin light 
chains are calcium binding proteins. J.  BhgL Chem.  262:25-28. 
26. Nandi, P. K., H. T. Pretorius, R. E. Lippoldt, M. L. Johnson, and H. Edel- 
hoch.  1980.  Molecular properties of the reassembled coat protein of 
coated vesicles. Biochemistry.  19:5917-5921. 
27. Parbam, P., M. J. Androlewicz, F. M. Brodsky, N. J. Holmes, and J. P. 
Ways. 1982. Monoclonal antibodies: purification, fragmentation, and ap- 
plication to structural and functional studies of Class I MHC antigens. 
J. lmmunol.  Methods. 53:133-173. 
28. Pearse, B.  M. F.  1978.  On the structural and functional components of 
coated vesicles. J.  Mol.  Biol.  126:803-812. 
29. Pearse, B.  M.  F., and M.  S. Bretscber.  1981.  Membrane recycling by 
coated vesicles. Armu.  Rev. Biochem.  50:85-101. 
30. Pearse, B. M. F., and M. S. Robinson. 1984.  Purification  and properties 
of  100kd  proteins from coated vesicles and their reconstitution with 
clathrin. EMBO (Eur.  Mol. Biol.  Organ.) J.  3:1951-1957. 
31. Schmid, S. L., W. A. Braell, D. M. Schlossman, andL E. Rothman. 1984. 
A role for clathrin light chains in the recognition of clathrin cages by "un- 
coating ATPase." Nature (Lond.).  3 ! 1:228-231. 
32. Schmid, S. L., A. K. Matsumoto, and J. E. Rothman. 1982. A domain of 
clathrin that forms coats. Proc. Natl. Acad. Sci.  USA.  79:91-95. 
33. Schook, W., and S. Puszkin. 1985. Brain clathrin light chain 2 can be phos- 
phorylated by  a  coated vesicle kinase.  Proc.  Natl.  Acad.  Sci.  USA. 
82:8039-8043. 
34. Schook, W., S.  Puszkin, B. William, C.  Ores, and S. Kochwa.  1979. 
Mechanocbemical properties of brain clathrin: interactions with actin and 
a-actin and polymerization into basket-like structures or filaments. Proc. 
Natl. Acad.  Sei.  USA.  76:116-120. 
35. Sorger, P. K., R. A. Crowtber, J. T. Finch, and B. M. F. Pearse. 1986. 
Clathrin cubes: an extreme variant of the normal cage. J.  Cell Biol. 
103:1213-1219. 
36. Steinert, P. M., A. C. Steven, and D. R. Roop. 1985. The molecular biol- 
ogy of intermediate filaments. Cell. 42:411-419. 
37. Tyler, J. M., and D, Branton. 1980. Rotary shadowing of extended mole- 
cules dried from glycerol. J.  Ultrastruct.  Res. 71:95-102. 
38. Ungewickell, E. 1983. Biochemical and immunological studies on clathrin 
light chains and their binding sites on clathrin triskelions. EMBO (Eur. 
biol.  Biol.  Organ.)J.  2:1401-1408. 
39. Ungewickell, E., and D. Branton. 1981. Assembly units of clathrin coats. 
Nature (Lord.).  289:420--422, 
40. Ungewickell, E.,  E.  R. Unanue, and D. Branton.  1982.  Functional and 
structural studies on clathrin triskelions and baskets. Cold Spring Harbor 
Syrup.  Quant.  Biol.  46:723-731. 
41. Usami, M., A. Takahashi, T. Kadota, and K. Kadota. 1985. Phosphoryla- 
tion of clathrin light chain or coated vesicles in the presence of histories. 
J.  Biochem.  97:1819-1822. 
42. Vigers, G. P. A., R. A. Crowther, and B. M. F. Pearse.  1986.  Three- 
dimensional structure of clathrin cages in ice. EMBO (Fur.  Mol.  Biol. 
Organ.) J~ 5:529-534. 
43. Winkler, F. K., and K. K. Stanley. 1983. Clathrin heavy chain, light chain 
interaction. EMBO (Eur.  Idol.  Biol.  Organ.) J. 2:1393-1400. 
44. Woodward, M. P., and T. F. Roth.  1978.  Coated vesicles: characteriza- 
tion, selective dissociation, and reassembly. Proc. Natl. Acad. Sci. USA. 
75:4394-4398. 
Blank and Brodsky Clathrin  Assembly Interaction  Sites  2019 